Company Overview and News
WHILE crude oil has rebounded to over US$80 per barrel and sentiment on the oil and gas sector has turned bullish, the recovery in prices may not lift all players in the industry.
4456 7251 5183 PECGF 5141 HIPEF 5256 5199
Kenanga Research added that green field-based projects, such as exploration or new-oil production based jobs, could see a lagged surge, given its huge capex nature and drawn-out planning process. The research house said the companies likely to benefit from this would be those with direct exploration and production (E&P) exposure such as Sapura Energy Bhd, Reach Energy Bhd and Hibiscus Petroleum Bhd.
7293 5141 HIPEF 5256 5199
Dayang Enterprise Holdings Bhd (Aug 30, 75 sen) Reiterate outperform with an unchanged target price (TP) of 98 sen: Dayang Enterprise Holdings Bhd last week announced it had secured a provision of Pan Malaysia maintenance, construction, and modification (PM-MCM) contract win from JX Nippon Oil & Gas Exploration (Malaysia) Ltd, for five years up to 2023. While no value was mentioned, we guesstimate a value of about RM100 million to RM200 million, bringing year-to-date (YTD) contract wins to about RM1.
KUALA LUMPUR: Econpile Holdings Bhd , Destini Bhd , Sentoria Group Bhd and Dayang Enterprise Holdings Bhd are among the stocks to watch today, according to JF Apex Research.
4634 GMALY BSTHY 4715 GMALF 5253 5141 5213 2771 GEBHF
KUALA LUMPUR (Aug 29): Based on corporate announcements and news flow today, stocks in focus on Monday (Aug 30) may include Econpile Holdings Bhd, Destini Bhd, Sentoria Group Bhd, Dayang Enterprise Holdings Bhd, Telekom Malaysia Bhd, Bumi Armada Bhd, CIMB Group Holdings Bhd, Taliworks Corp Bhd, YTL Corp Bhd, Pos Malaysia Bhd, Genting Malaysia Bhd, UMW Holdings Bhd, PPB Group Bhd, Boustead Holdings Bhd and 7-Eleven Malaysia Holdings Bhd.
BSTHY WLMIF BRDBF GMALF 4065 5253 5141 6742 5213 2771 CIMDF 5210 4634 GMALY WLMIY 1023 4588 4863 4715 YTLPF MYTEF BSMAF F34 1818
KUALA LUMPUR (Aug 29): Dayang Enterprise Holdings Bhd’s wholly-owned unit Dayang Enterprise Sdn Bhd has secured a five-year contract from JX Nippon Oil & Gas Exploration (Malaysia) Ltd for the provision of maintenance, construction and modification services throughout Malaysia.
TRADING of the shares in Dayang Enterprise Holdings Bhd (fundamental: 0.2/3; valuation: 0.9/3) triggered our momentum algorithm yesterday for the fourth time this year. The group saw 5.41 million shares traded, compared with its 200-day average of 2.22 million shares.
KUALA LUMPUR (Aug 27): Public Investment Bank Bhd revised its Dayang Enterprise Holdings Bhd share target price (TP) to 84 sen, which implies a higher price-earnings multiple of 12 times, as Public Investment opines that the worst is finally over for the oil and gas support services provider.
KUALA LUMPUR: JF Apex Research expects Sapura Energy Bhd , Cahya Mata Sarawak Bhd (CMSB), Southern Steel Bhd , Dayang Enterprise Holdings Bhd and Axiata Group Bhd to be among the stocks to watch on Monday.
4634 2852 0146 5665 6888 5141 AXXTF 7155
KUALA LUMPUR (Aug 24): Based on corporate announcements and news flow today, companies that will be in focus on Monday (Aug 27) may include: Sapura Energy Bhd, PUC Bhd, Axiata Group Bhd, Cahya Mata Sarawak Bhd, Magnum Bhd, Southern Steel Bhd, Dayang Enterprise Holdings Bhd, SKP Resources Bhd, MMC Corp Bhd, MSM Malaysia Holdings Bhd, Pos Malaysia Bhd, Paramount Corp Bhd and Adventa Bhd.
4634 2852 5665 6888 IDEA 5141 ICLQY AXXTF 5202 532822 7155
KUALA LUMPUR (Aug 24): Dayang Enterprise Holdings Bhd has returned to the black with a net profit of RM38.85 million for the second quarter ended June 30, 2018 compared to a net loss of RM48.10 million in the same quarter last year, on higher work orders.
5141 BSMAF 1818
KUALA LUMPUR (Aug 24): After five straight quarters of losses, Perdana Petroleum Bhd was back in the black with a net profit of RM10.09 million for the second quarter ended June 30, 2018.
KUALA LUMPUR (Aug 20): Based on corporate announcements and news flow today, companies in focus on Tuesday (Aug 21) may include the following: Utusan Melayu (Malaysia) Bhd, Petrol One Resources Bhd, Eita Resources Bhd, Gadang Holdings Bhd, Dayang Enterprise Holdings Bhd, Petronas Dagangan Bhd, Allianz Malaysia Bhd, United Plantations Bhd, Eastern and Oriental Bhd (E&O), Velesto Energy Bhd, Amway (Malaysia) Holdings Bhd and Rex Industry Bhd.
9261 UPBMF 5681 5141 7027 1163 2089 5754 5209 5208 9946 BSMAF 1818
KUALA LUMPUR (Aug 20): Dayang Enterprise Holdings Bhd has secured two five-year maintenance, construction and modification contracts via its wholly-owned subsidiary Dayang Enterprise Sdn Bhd (DESB).
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...